Key result
Diverse cardiac macrophages drive inflammation, tissue repair, and metabolic reprogramming across various heart diseases.
Understanding the origins, metabolic reprogramming, and functional diversity of cardiac macrophages offers promising therapeutic targets for treating cardiac diseases such as myocardial infarction, heart failure, and arrhythmias.
May guide macrophage-targeted therapies in cardiac disease; leaves open clinical translation pending prospective validation.
Macrophages are important immune cells for cardiac development, homeostasis, and the response to pathological injury and inflammation. Single-cell sequencing and fate-mapping technologies have revealed the heterogeneity and development of cardiac macrophages. They are classed into two main groups: embryonic tissue-resident and bone marrow-derived macrophages. These different macrophage subsets show complex functions in cardiac diseases such as inflammation regulation, tissue repair, metabolic reprogramming and intercellular communication within the cardiac microenvironment. This review discusses the developmental sources, phenotypic diversity, metabolic features and mechanistic functions of cardiac macrophages in different cardiac disorders. We focus on macrophage polarization, metabolic regulation during disease progression and targeted strategies and future research directions.
No takes yet. Share an insight, caveat, or question.
Che et al. (2026) conducted a review in Cardiac diseases. Cardiac macrophages exhibit significant heterogeneity and functional diversity, playing crucial roles in inflammation, tissue repair, and metabolic reprogramming across various cardiac diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: